Cost of illness of metastatic prostate cancer: a perspective of costs for new treatment options in The Netherlands

被引：2
作者：
ter Heine, Rob [1 ]
Frederix, Geert W. J. [2 ]
Geenen, Joost W. [3 ]
Hovels, Anke M. [3 ]
van Vulpen, Marco [4 ]
Kooistra, Anko [5 ]
De Klerk, John M. H. [6 ]
Bloemendal, Haiko J. [7 ]
机构：
[1] Radboudumc, Dept Pharm, Geert Grootepl Zuid 22, NL-6525 GA Nijmegen, Netherlands
[2] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Univ Weg 100, NL-3584 CG Utrecht, Netherlands
[3] Univ Utrecht, Fac Sci, Dept Pharmaceut Sci, Univ Weg 99, NL-3584 CG Utrecht, Netherlands
[4] Univ Med Ctr Utrecht, Dept Radiotherapy, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands
[5] Meander Med Ctr, Dept Urol, Maatweg 3, NL-3813 TZ Amersfoort, Netherlands
[6] Meander Med Ctr, Dept Nucl Med, Maatweg 3, NL-3813 TZ Amersfoort, Netherlands
[7] Meander Med Ctr, Dept Internal Med, Maatweg 3, NL-3813 TZ Amersfoort, Netherlands
来源：
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH | 2017年 / 6卷 / 07期
关键词：
bone metastases; cost of illness; prostate cancer; radionuclide therapy; skeletal-related events; SKELETAL-RELATED EVENTS; BONE METASTASES; OF-ILLNESS; MORTALITY; RADIOTHERAPY; PREVALENCE; COUNTRIES; PATTERNS; TRENDS;
D O I：
10.2217/cer-2017-0026
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
Aim: To assess the resource use and associated costs of treating patients with metastatic prostate cancer with a focus on skeletal-related events (SREs). Methods: We performed a bottom-up cost of illness study in The Netherlands. Results: A total of 136 patients were studied. The mean total costs were (sic)17,931 per patient. SREs that required hospitalization (n = 53) were, at median costs of (sic)2039-9346, depending on care. These SREs had median costs of (sic)200-1912. Conclusion: Our data provide a basis to investigate the cost-effectiveness of novel treatment options for metastatic prostate cancer. The impact of SREs on total costs could justify policy aimed at actively preventing SREs, possibly resulting in better quality of life and cost-reduction.
引用
收藏
页码：575 / 581
页数：7
相关论文
共 27 条
  • [1] The role of external beam radiotherapy in the management of bone metastases
    Agarawal, J. P.
    Swangsilpa, T.
    van der Linden, Y.
    Rades, D.
    Jeremic, B.
    Hoskin, P. J.
    [J]. CLINICAL ONCOLOGY, 2006, 18 (10) : 747 - 760
  • [2] [Anonymous], POP STRUCT AG
  • [3] Autoriteit NZ, 2013, TAR DBC ZORGPR OV PR
  • [4] Health resource utilization associated with skeletal-related events: results from a retrospective European study
    Body, Jean-Jacques
    Pereira, Joao
    Sleeboom, Harm
    Maniadakis, Nikos
    Terpos, Evangelos
    Acklin, Yves Pascal
    Finek, Jindrich
    Gunther, Oliver
    Hechmati, Guy
    Mossman, Tony
    Costa, Luis
    Rogowski, Wojciech
    Nahi, Hareth
    von Moos, Roger
    [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2016, 17 (06) : 711 - 721
  • [5] Prostate cancer incidence and mortality trends in 37 European countries: An overview
    Bray, F.
    Lortet-Tieulent, J.
    Ferlay, J.
    Forman, D.
    Auvinen, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2010, 46 (17) : 3040 - 3052
  • [6] When to Perform Bone Scan in Patients with Newly Diagnosed Prostate Cancer: External Validation of the Currently Available Guidelines and Proposal of a Novel Risk Stratification Tool
    Briganti, Alberto
    Passoni, Niccolo
    Ferrari, Matteo
    Capitanio, Umberto
    Suardi, Nazareno
    Gallina, Andrea
    Da Pozzo, Luigi Filippo
    Picchio, Maria
    Di Girolamo, Valerio
    Salonia, Andrea
    Gianolli, Liugi
    Messa, Cristina
    Rigatti, Patrizio
    Montorsi, Francesco
    [J]. EUROPEAN UROLOGY, 2010, 57 (04) : 551 - 558
  • [7] Budget Impact of Enzalutamide for Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer
    Bui, Cat N.
    O'Day, Ken
    Flanders, Scott
    Oestreicher, Nina
    Francis, Peter
    Posta, Linda
    Popelar, Breanna
    Tang, Hong
    Balk, Mark
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2016, 22 (02) : 163 - U171
  • [8] Cost-of-illness studies in the United States: A systematic review of methodologies used for direct cost
    Clabaugh, Gerd
    Ward, Marcia M.
    [J]. VALUE IN HEALTH, 2008, 11 (01) : 13 - 21
  • [9] Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
    Ferlay, J.
    Steliarova-Foucher, E.
    Lortet-Tieulent, J.
    Rosso, S.
    Coebergh, J. W. W.
    Comber, H.
    Forman, D.
    Bray, F.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 (06) : 1374 - 1403
  • [10] Costs of prostate cancer, metastatic to the bone, in The Netherlands
    Groot, MT
    Kruger, CGGB
    Pelger, RCM
    Uyl-de Groot, CA
    [J]. EUROPEAN UROLOGY, 2003, 43 (03) : 226 - 232
123